Keymed Biosciences Inc. (HKG:2162)
Hong Kong
· Delayed Price · Currency is HKD 73.90
+0.95 (1.30%)
Aug 15, 2025, 4:08 PM HKT
Keymed Biosciences Market Cap
Keymed Biosciences has a market cap or net worth of 21.77 billion as of August 15, 2025. Its market cap has increased by 154.31% in one year.
Market Cap
21.77B
Enterprise Value
20.28B
Revenue
455.60M
Ranking
n/a
PE Ratio
n/a
Stock Price
73.90
Market Cap Chart
Since July 8, 2021, Keymed Biosciences's market cap has increased from 18.43B to 21.77B, an increase of 18.14%. That is a compound annual growth rate of 4.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 15, 2025 | 21.77B | 155.65% |
| Dec 31, 2024 | 8.52B | -37.32% |
| Dec 29, 2023 | 13.59B | -4.15% |
| Dec 30, 2022 | 14.17B | 46.87% |
| Dec 31, 2021 | 9.65B | -47.63% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 265.60B |
| Hansoh Pharmaceutical Group Company | 226.30B |
| JD Health International | 179.05B |
| Innovent Biologics | 162.71B |
| Akeso | 147.38B |
| Sino Biopharmaceutical | 137.89B |
| WuXi Biologics | 125.45B |
| CSPC Pharmaceutical Group | 119.48B |